Sean Matthews

588 total citations
21 papers, 356 citations indexed

About

Sean Matthews is a scholar working on Epidemiology, Dermatology and Pharmacology. According to data from OpenAlex, Sean Matthews has authored 21 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 12 papers in Dermatology and 6 papers in Pharmacology. Recurrent topics in Sean Matthews's work include Herpesvirus Infections and Treatments (18 papers), Acne and Rosacea Treatments and Effects (11 papers) and Healthcare and Venom Research (6 papers). Sean Matthews is often cited by papers focused on Herpesvirus Infections and Treatments (18 papers), Acne and Rosacea Treatments and Effects (11 papers) and Healthcare and Venom Research (6 papers). Sean Matthews collaborates with scholars based in Belgium, United States and Australia. Sean Matthews's co-authors include Desmond Curran, Ruprecht Schmidt‐Ott, Myron J. Levin, Lidia Oostvogels, Kenneth E. Schmader, Javier Díez‐Domingo, Toshihiko Kaise, Akiko Mizukami, Koichi Adachi and Keiko Sato and has published in prestigious journals such as Journal of the American Geriatrics Society, The Journals of Gerontology Series A and Clinical Journal of Pain.

In The Last Decade

Sean Matthews

20 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sean Matthews Belgium	12	289	112	103	52	38	21	356
Ryan Thompson United States	8	127 0.4×	49 0.4×	20 0.2×	16 0.3×	17 0.4×	13	208
Yvonne J. Bryson United States	5	203 0.7×	66 0.6×	41 0.4×	27 0.5×	12 0.3×	5	246
Lotfollah Davoodi Iran	11	72 0.2×	31 0.3×	34 0.3×	14 0.3×	4 0.1×	51	294
Ángel Hernández Merino Spain	10	165 0.6×	33 0.3×	4 0.0×	29 0.6×	19 0.5×	31	311
Stefano Frenos Italy	9	154 0.5×	3 0.0×	21 0.2×	27 0.5×	4 0.1×	15	312
Dilek Yılmaz Çiftdoğan Türkiye	10	129 0.4×	9 0.1×	9 0.1×	21 0.4×	3 0.1×	52	273
Nakul Shekhawat United States	10	66 0.2×	12 0.1×	5 0.0×	8 0.2×	4 0.1×	26	280
Ilenia Pepe Italy	10	57 0.2×	9 0.1×	102 1.0×	9 0.2×	22 0.6×	16	418
R Ganapati India	10	169 0.6×	15 0.1×	8 0.1×	9 0.2×	31 0.8×	71	431
K Blot Belgium	8	60 0.2×	2 0.0×	32 0.3×	11 0.2×	26 0.7×	15	283

Countries citing papers authored by Sean Matthews

Since Specialization

Citations

This map shows the geographic impact of Sean Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Matthews more than expected).

Fields of papers citing papers by Sean Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Matthews. The network helps show where Sean Matthews may publish in the future.

Co-authorship network of co-authors of Sean Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Matthews. A scholar is included among the top collaborators of Sean Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Matthews. Sean Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curran, Desmond, et al.. (2025). The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide. Infectious Diseases and Therapy. 14(6). 1327–1341.

Curran, Desmond, Sean Matthews, Silvia Narejos Pérez, et al.. (2024). The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus‐associated disease in breakthrough infections in adults ≥60 years of age. Influenza and Other Respiratory Viruses. 18(2). e13236–e13236. 12 indexed citations

Matthews, Sean, Desmond Curran, Céline Boutry, et al.. (2023). An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies. Clinical Journal of Pain. 39(8). 386–393. 3 indexed citations

Curran, Desmond, Sean Matthews, Céline Boutry, et al.. (2022). Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials. Infectious Diseases and Therapy. 11(6). 2265–2277. 6 indexed citations

Andrew, Melissa K., et al.. (2022). An Easy-to-Implement Clinical-Trial Frailty Index Based on Accumulation of Deficits: Validation in Zoster Vaccine Clinical Trials. Clinical Interventions in Aging. Volume 17. 1261–1274. 3 indexed citations

Díez‐Domingo, Javier, et al.. (2021). Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study. Advances in Therapy. 38(6). 3325–3341. 24 indexed citations

Curran, Desmond, et al.. (2021). Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany. Human Vaccines & Immunotherapeutics. 17(12). 5296–5303. 17 indexed citations

Callegaro, Andrea, Desmond Curran, & Sean Matthews. (2020). Burden‐of‐illness vaccine efficacy. Pharmaceutical Statistics. 19(5). 636–645. 6 indexed citations

Schmader, Kenneth E., Myron J. Levin, Michael Chen, et al.. (2020). Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults. The Journals of Gerontology Series A. 76(3). 485–490. 12 indexed citations

10.

Curran, Desmond, Sean Matthews, Myron J. Levin, et al.. (2020). Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals. Journal of the American Geriatrics Society. 69(3). 744–752. 36 indexed citations

11.

Matthews, Sean, et al.. (2019). The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy. Open Forum Infectious Diseases. 6(2). ofz007–ofz007. 19 indexed citations

12.

Curran, Desmond, Melissa K. Andrew, Myron J. Levin, et al.. (2019). Evaluation of two frailty indices, with practical application in a vaccine clinical trial. Human Vaccines & Immunotherapeutics. 15(12). 2960–2968. 8 indexed citations

13.

Schmidt‐Ott, Ruprecht, B Poulsen Nautrup, Alfred von Krempelhuber, et al.. (2018). Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study. Journal of Infection. 76(5). 475–482. 31 indexed citations

14.

Curran, Desmond, et al.. (2018). Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above. BMC Infectious Diseases. 18(1). 496–496. 48 indexed citations

15.

Curran, Desmond, Lidia Oostvogels, Thomas C. Heineman, et al.. (2018). Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older. The Journals of Gerontology Series A. 74(8). 1231–1238. 43 indexed citations

16.

Schmader, Kenneth E., Myron J. Levin, Sean Matthews, et al.. (2018). 2488. The Impact of Reactogenicity After Administration of the Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults. Open Forum Infectious Diseases. 5(suppl_1). S746–S747. 1 indexed citations

17.

Nakamura, Hiroyuki, Akiko Mizukami, Koichi Adachi, et al.. (2017). Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan. Drugs - Real World Outcomes. 4(4). 187–198. 16 indexed citations

18.

Mizukami, Akiko, Keiko Sato, Koichi Adachi, et al.. (2017). Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study. Clinical Drug Investigation. 38(1). 29–37. 39 indexed citations

19.

Curran, Desmond, et al.. (2016). Herpes Zoster And Postherpetic Neuralgia: Quality Of Life And Healthcare Utilization, A German Study. Value in Health. 19(7). A420–A420. 1 indexed citations

20.

Curran, Desmond, Eugene Athan, Javier Díez‐Domingo, et al.. (2016). Quality-of-Life Impact of an Investigational Subunit-Adjuvanted Herpes Zoster Vaccine in Adults ≥50 Years of Age. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact